Back to results
US 2015/0104414 A1Published application
Cytokines and neuroantigens for treatment of immune disorders
AssigneeEast Carolina University
InventorMark D. Mannie
Life of this patent
Estimating the term…
Abstract
The present invention provides methods of regulating an immunological disorder comprising administering to a subject an effective amount of (i) an autoimmune antigen in conjunction with (ii) an anti-inflammatory cytokine. Compositions including the same are also provided.
Claims20
1-35. (canceled)
A composition comprising:
- (a) at least one fusion protein comprising (i) an autoimmune antigen selected from the group consisting of myelin basic protein (MBP), proteolipid protein (PLP), myelin oligodendrocyte glycoprotein (MOG) and myelin-associated oligodendrocytic basic protein, or portions thereof;
- (ii) optionally an enterokinase linking moiety, wherein the enterokinase linking moiety is (1) an amino acid sequence of SEQ ID NO:1, (2) an amino acid sequence having at least 80% identity or homology with the amino acid sequence of SEQ ID NO:1, (3) an amino acid sequence encoded by a nucleic acid sequence encoding an enterokinase recognition site, or (4) an amino acid sequence encoded by a nucleic acid sequence that hybridizes with the complement of the nucleic acid sequence of (3) under stringent conditions as represented by hybridization conditions of 0.5M NaHPO4, 7% sodium dodecyl sulfate (SDS), 1 mM EDTA at 65° C. and wash conditions of 0.1×SSC/0.1% SDS at 68° C.;
- and (iii) an anti-inflammatory cytokine;
- (b) an anti-inflammatory cytokine;
- and
- (c) a pharmaceutically acceptable carrier, excipient or diluent.
3 more elements
Dependencies are inferred from the claim text.